Immunocore reports fourth quarter and full year 2023 financial results and provides a business update KIMMTRAK (tebentafusp) net revenues of $67.6 million in Q4 2023 and $238.7 million in 2023; increasing commercial access to KIMMTRAK globally, and pursuing future growth opportunities with two registrational trials in advanced cutaneous melanoma and adjuvant uveal melanoma Clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) with nivolumab in regi ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts, on Monday, March 4, 2024. Roland Chen, M.D., senior vice president, Immunology, Cardiovascular & Neuroscience development, will answer questions about the company during a fireside chat at 9:50 a.m. ET. Investors and the general public are invited to listen to a live webcast of the session here. An archived edition ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) announced today that it has successfully completed its acquisition of RayzeBio, Inc. (NASDAQ: RYZB). With the completion of the acquisition, RayzeBio shares have ceased trading on the NASDAQ Global Market and RayzeBio is now a wholly owned subsidiary of Bristol Myers Squibb. “We are excited to complete this transaction, which adds radiopharmaceutical therapeutics (RPTs), one of the fastest-growing new modalities for treating patients with ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Blackstone Mortgage Trust, Inc. (BXMT) is a real estate finance company. The Zacks Consensus Estimate for its current year earnings has been revised 11.6% downward over the last 60 days.Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 8.5% downward over the last 60 days.Clearway Energy, Inc. (CWEN) is a renewable energy company.The Zacks Cons ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the “Offer”) to acquire all of the outstanding shares of RayzeBio, Inc. (Nasdaq: RYZB) common stock for a purchase price of $62.50 per share in cash, or approximately $4.1 billion, expired at one minute after 11:59 p.m., Eastern Time, on February 22, 2024 (the “Expiration Time”). Equiniti Trust Company, the depositary for the Offer, has advised that, as of the Expiration Time, appr ...

Bristol Myers (BMY) announced that the FDA has accepted its supplemental new drug application (sNDA) for Krazati (adagrasib) in combination with Erbitux (cetuximab) to treat patients with previously treated KRASG12C-mutated locally advanced or metastatic (la/m) colorectal cancer (CRC). The FDA has assigned the Priority Review status to the company’s sNDA for the combination therapy.A filing designated as a Priority Review reduces the review period by four months. A final decision from the regulatory body is ...

PHILADELPHIA, PENNSYLVANIA - OCTOBER 19: Amanda Poole, Senior Vice President, HR, Bristol Myers ... [+] Squibb speaks on stage during 2023 Pennsylvania Conference For Women at Pennsylvania Convention Center on October 19, 2023 in Philadelphia, Pennsylvania. (Photo by Marla Aufmuth/Getty Images for Pennsylvania Conference For Women)Getty Images for Pennsylvania Conference For WomenBristol Myers Squibb BMY (NYSE: BMY) reported its Q4 results earlier this month, with revenues and earnings beating the street es ...

Picking the best stocks for beginning investors is crucial as they enter the world of long-term investing. With a myriad of options available, it’s essential to focus on stocks that offer growth potential and stability. Despite the short-term market volatility, investing in stocks remains one of the most reliable ways to build wealth over time.In this article, we’ll introduce three stocks for beginning investors that deserve your attention in February 2024. They not only provide a solid foundation for your ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that it has priced a public offering (the “Offering”) of senior unsecured notes in a combined aggregate principal amount of $13 billion (collectively, the “Notes”). The Notes will be issued in nine tranches: (i) $500,000,000 in aggregate principal amount of floating rate notes due 2026, (ii) $1,000,000,000 in aggregate principal amount of 4.950% notes due 2026, (iii) $1,000,000,000 in aggregate principal amount of 4.900% note ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that it recently became aware of an unsolicited “mini-tender” offer by Tutanota LLC (“Tutanota”) to purchase up to five hundred thousand shares of Bristol Myers Squibb’s common stock, representing significantly less than one percent of Bristol Myers Squibb’s common stock outstanding, at an offer price of $55 per share (“Offer Price”). The offer is conditioned on, among other things, the closing price per share of Bristol Mye ...